Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Mission Bio Launches Tapestri v3 to Rapidly Accelerate Rare Cell Detection Applications for Translational Research and Precision Therapeutics
Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced breakthrough improvements […]
Touchlight Completes Expansion, Creating One of the World’s Largest DNA Manufacturing Facilities in London
Touchlight, a company pioneering enzymatic DNA production, a critical material in many new genetic medicine […]
Chroma Medicine Announces Data Demonstrating the Benefits of Epigenetic Editing for Multiplex Gene Regulation
Chroma Medicine, a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today presented data demonstrating […]
NeoPhore Signs Research Collaboration with The Institute of Cancer Research, London
NeoPhore, a small molecule neoantigen immuno-oncology company, today announces that it has signed a strategic […]
BGI Genomics Partners with Zentya to Launch Fecal DNA Test for Colorectal Cancer in Slovakia
BGI Genomics is pleased to announce the launch of COLOTECTTM 1.0 in Slovakia, in collaboration […]
Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa
Illumina, a global leader in DNA sequencing and array-based technologies, and GenoScreen, an innovative genomics […]
Debiopharm Extends Their DNA Damage Repair Footprint With New Oncology Pipeline Entry
Debiopharm, an independent Swiss-based, biopharmaceutical company aiming to develop tomorrow’s standard-of-care treatments to cure cancer […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more